#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4710	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2112	390.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1467	1467	C	507	C	300	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8646	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3578	409.5	0	.	n	.	0	T695C	SNP	695	695	T	948	948	C	479	C	266	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8646	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3578	409.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1590	1590	A	440	A,G,T	182,83,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8646	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3578	409.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2224	2224	C	460	C	281	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8646	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3578	409.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2298	2298	A	502	A	297	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8646	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3578	409.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2850	2850	C	429	C,T	144,112	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8646	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3578	409.5	0	HET	.	.	.	C76CGGGGG,CGGGG	.	76	76	C	329	329	C	537	CGGGGG,CGGGG	237,82	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	302	folP	855	855	100.0	folP.l6.c4.ctg.1	1417	37.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1016	1018	AGC	48;50;50	A;G;C	26;28;27	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	928	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3369	47.7	0	.	p	.	0	T752P	NONSYN	2254	2256	ACC	2686	2688	CCC	17;17;17	C,A;C;C	0,9;11;11	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	928	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3369	47.7	1	SNP	p	S91F	1	.	.	271	273	TTC	703	705	TTC	60;60;60	T;T;C	35;36;34	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	928	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3369	47.7	1	SNP	p	D95N	0	.	.	283	285	GAC	715	717	GAC	70;72;72	G;A;C	41;40;40	gyrA.WHO_G_01105:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	928	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3369	47.7	1	SNP	p	D95G	0	.	.	283	285	GAC	715	717	GAC	70;72;72	G;A;C	41;40;40	gyrA.WHO_G_01105:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	232	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1351	29.9	1	SNP	p	G45D	1	.	.	133	135	GAC	501	503	GAC	67;67;67	G;A;C	40;40;38	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	186	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	942	33.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	786	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2921	47.1	1	SNP	p	D86N	0	.	.	256	258	GAC	546	548	GAC	63;63;63	G;A;C	42;37;38	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	786	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2921	47.1	1	SNP	p	S87I	0	.	.	259	261	AGT	549	551	AGT	61;61;63	A;G;T	37;41;38	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	786	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2921	47.1	1	SNP	p	S87W	0	.	.	259	261	AGT	549	551	AGT	61;61;63	A;G;T	37;41;38	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	786	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2921	47.1	1	SNP	p	S87R	0	.	.	259	261	AGT	549	551	AGT	61;61;63	A;G;T	37;41;38	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	27	786	parC	2304	2304	99.78	parC.l15.c4.ctg.1	2921	47.1	1	SNP	p	S88P	0	.	.	262	264	TCC	552	554	TCC	63;61;61	T;C;C	41;39;40	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	652	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2827	41.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1509	1511	GGC	34;34;34	G;G;C	20;20;21	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1151	1153	GCA	87;89;87	G;C;A	49;50;50	penA.4.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1154	1156	ATC	93;93;93	A;T;C,T	54;51;53,1	penA.4.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1166	1168	GTG	91;91;91	G;T;G	51;51;52	penA.4.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1166	1168	GTG	91;91;91	G;T;G	51;51;52	penA.4.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1670	1672	ACC	58;57;57	A;C;C	38;36;37	penA.4.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1724	1726	GCG	39;39;41	G;C;G	22;21;24	penA.4.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1724	1726	GCG	39;39;41	G;C;G	22;21;24	penA.4.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1847	1849	AGC	53;55;60	A;G;C	31;31;35	penA.4.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1856	1858	GGC	59;59;57	G;G;C	39;36;34	penA.4.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.4.001	penA.4.001	1	1	27	802	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2096	64.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1874	1876	CCG	55;54;53	C,G;C;G	28,2;24;23	penA.4.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1352	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	2849	76.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1511	1513	CCG	51;51;51	C;C;G	25;31;28	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	428	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1626	44.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	351	353	GGC	44;44;44	G;G;C	28;26;26	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	428	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1626	44.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	533	533	C	25	C	12	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	36	porB1a	984	104	94.23	porB1a.l15.c4.ctg.1	803	6.8	0	.	p	.	0	M18T	NONSYN	52	54	ATG	269	271	ACG	17;17;17	A;C;G	10;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	36	porB1a	984	104	94.23	porB1a.l15.c4.ctg.1	803	6.8	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	311	313	CAA	9;9;9	C;A;A	6;6;6	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	36	porB1a	984	104	94.23	porB1a.l15.c4.ctg.1	803	6.8	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	317	319	TAC	7;6;6	T;A;C	5;4;5	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	544	porB1b	1041	1041	99.04	porB1b.l15.c4.ctg.1	1650	58.9	0	.	p	.	0	S36Y	NONSYN	106	108	TCT	383	385	TAT	70;70;70	T;A;T	42;40;39	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	544	porB1b	1041	1041	99.04	porB1b.l15.c4.ctg.1	1650	58.9	0	.	p	.	0	K120D	NONSYN	358	360	AAG	635	637	GAC	62;62;64	G;A;C	41;40;42	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	544	porB1b	1041	1041	99.04	porB1b.l15.c4.ctg.1	1650	58.9	0	.	p	.	0	K208del	DEL	622	622	A	898	898	A	73	A	44	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	544	porB1b	1041	1041	99.04	porB1b.l15.c4.ctg.1	1650	58.9	0	.	p	.	0	G211S	NONSYN	631	633	GGC	905	907	AGC	66;66;64	A;G;C	41;40;38	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	544	porB1b	1041	1041	99.04	porB1b.l15.c4.ctg.1	1650	58.9	0	.	p	.	0	S216I	NONSYN	646	648	AGC	920	922	ATC	85;87;90	A;T;C	48;51;51	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	544	porB1b	1041	1041	99.04	porB1b.l15.c4.ctg.1	1650	58.9	0	.	p	.	0	I333T	NONSYN	997	999	ATC	1271	1273	ACC	92;92;92	A;C;C	52;52;51	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2322	rpoB	4179	4179	99.95	rpoB.l15.c30.ctg.1	4971	79.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	190	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	895	38.4	1	SNP	p	V57M	1	.	.	169	171	ATG	444	446	ATG	65;69;71	A;T;G	37;39;39	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
